Governor Patrick and Israeli Chief Scientist Avi Hasson Announce First Round of Massachusetts-Israel Innovation Partnership Grants at Biotechnology Industry Organization

Galectin Therapeutics Inc. and SBH Sciences, Inc. Announce the Formation of Galectin Sciences, LLC, a Collaborative Venture to Research and

SBH Sciences coauthors Genervon Biopharmaceuticals study “GM604- A multiple-target regulator that provides a novel therapeutic strategy for treatment of ALS

Cellaria Forms Collaborative Partnership with SBH Sciences Combines SBH’s assay services with Cellaria’s patient-specific cell models and cell culture media

SBH Offers ELLA Platform for COVID-19 and Cytokine-storm Research (Natick, MA)  April 10, 2020. As the world continues to fight

MedChem Partners LLC and SBH Sciences have teamed up to offer an integrated solution for drug discovery (Lexington, MA, and

Recombinant Human Activin-A: Scientific background and Collaboration Opportunity Scientific backgroundActivin A is a member of the TGF-β family that exhibits

Recombinant Human BMP-7 / OP-1: Scientific background and Collaboration Opportunity Scientific backgroundBone Morphogenetic protein 7 (BMP7), also known as osteogenic

Human CD22 : Scientific background and Collaboration Opportunity Scientific backgroundCD22 is a cell surface molecule belonging to the SIGLEC family of

Soluble Interleukin-6 receptor (sIL-6R) Scientific backgroundInterleukin-6 (IL-6) is a multifunctional cytokine that regulates pleiotropic roles in immune regulation, inflammation, hematopoiesis,

Recombinant Human MIC-1 / NAG-1 / GDF-15: Scientific Background and Collaboration Opportunity Scientific BackgroundMacrophage inhibitory cytokine 1 (MIC-1), also known

Recombinant Human and Murine HGF: Scientific background and Collaboration Opportunity Scientific backgroundHepatocyte Growth Factor (HGF), also known as Scatter Factor (SF) and

Recombinant Human Interleukin 23Scientific Background and Collaboration Opportunity Scientific backgroundInterleukin 23 (IL-23) is a heterodimeric cytokine belonging to the IL-6

Cytokines are small proteins that are produced by cells of the immune system. They play a vital role in regulating

The Sonic Hedgehog (Shh) protein is a signaling molecule that plays a critical role in the development of many tissues

Antibody-dependent cellular cytotoxicity (ADCC) is a mechanism of cell-mediated immune defense whereby an effector cell of the immune system kills a

Tube Formation Bioassay: A Versatile Tool for Studying Angiogenesis Angiogenesis is the process of forming new blood vessels from pre-existing

When we fall ill from infections or other medical conditions, our bodies respond with a complex orchestration of immune reactions.

The FDA Modernization ACT 2.0 was signed into law by President Biden on December 29, 2022. The bill stands as

Polymerase chain reaction (PCR) has revolutionized molecular biology and diagnostics by amplifying minute quantities of DNA, to levels where they can be

Organoids are miniature, simplified versions of organs that are produced in vitro from stem cells, primary cells and cancer cells.

The THP-1 cell line, derived from human leukemia monocytic cells, is widely used in drug discovery research to explore mechanisms,

Innovative Luminex Technology Luminex Corporation is a leading biotechnology company that develops, manufactures, and markets proprietary biological testing technologies used

Ella Principles: The Ella automated ELISA system, developed by ProteinSimple, a Bio-Techne brand, is a sophisticated instrument designed to automate and

Previously, we highlighted the impressive capabilities of the Ella automated ELISA system. While Ella offers speed and automation, it’s important to

Following our recent discussion on ELISA we’re now highlighting AlphaLISA – a powerful alternative with enhanced sensitivity, no wash steps, and scalability

In our previous blogs, we explored AlphaLISA and HTRF in detail, highlighting their unique strengths. Both advanced assay technologies offer exceptional sensitivity and are well-suited

A Q&A with Dr. Batista Jr. and Dr. Dariolli from Bonds Biosystems The future of cancer research is rapidly evolving, driven

We previously spoke about AlphaLISA, a powerful assay technology with enhanced sensitivity, no wash steps, and scalability for high-throughput screening. This